D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
-10.3%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$61.5B
AUM Growth
-$14.6B
Cap. Flow
-$10.1B
Cap. Flow %
-16.36%
Top 10 Hldgs %
10.78%
Holding
4,727
New
431
Increased
1,418
Reduced
1,362
Closed
552

Sector Composition

1 Technology 17.19%
2 Financials 14.3%
3 Healthcare 10.79%
4 Consumer Discretionary 9.85%
5 Industrials 7.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SCOB
901
DELISTED
ScION Tech Growth II Class A Ordinary Shares
SCOB
$9.37M 0.01%
956,574
+451,003
+89% +$4.42M
WDC icon
902
Western Digital
WDC
$32.8B
$9.36M 0.01%
276,316
-1,436,487
-84% -$48.7M
CRNC icon
903
Cerence
CRNC
$403M
$9.35M 0.01%
370,647
+49,161
+15% +$1.24M
OBIO icon
904
Orchestra BioMed
OBIO
$139M
$9.35M 0.01%
938,388
+51,487
+6% +$513K
MFC icon
905
Manulife Financial
MFC
$52.3B
$9.34M 0.01%
538,940
+280,640
+109% +$4.87M
SLQT icon
906
SelectQuote
SLQT
$339M
$9.32M 0.01%
3,756,277
-717,837
-16% -$1.78M
FOXO
907
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$9.31M 0.01%
4,671
FLO icon
908
Flowers Foods
FLO
$3.03B
$9.3M 0.01%
353,333
-255,183
-42% -$6.72M
CCVI
909
DELISTED
Churchill Capital Corp VI
CCVI
$9.3M 0.01%
949,913
VNDA icon
910
Vanda Pharmaceuticals
VNDA
$266M
$9.29M 0.01%
851,978
+182,831
+27% +$1.99M
ASND icon
911
Ascendis Pharma
ASND
$12B
$9.28M 0.01%
99,782
-52,177
-34% -$4.85M
SLCA
912
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$9.27M 0.01%
811,481
-186,681
-19% -$2.13M
DPCS
913
DELISTED
DP Cap Acquisition Corp I Class A Ordinary Shares
DPCS
$9.26M 0.01%
930,831
+300
+0% +$2.99K
RYI icon
914
Ryerson Holding
RYI
$706M
$9.23M 0.01%
433,295
+75,444
+21% +$1.61M
GSAQ
915
DELISTED
Global Synergy Acquisition Corp. Class A Ordinary Shares
GSAQ
$9.22M 0.01%
925,267
COO icon
916
Cooper Companies
COO
$13.5B
$9.21M 0.01%
117,668
+67,540
+135% +$5.29M
BIOT
917
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
$9.2M 0.01%
929,085
CFIV
918
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$9.2M 0.01%
934,454
+58,793
+7% +$579K
NCAC
919
DELISTED
Newcourt Acquisition Corp Class A Ordinary Share
NCAC
$9.19M 0.01%
914,171
+177,803
+24% +$1.79M
TGAA
920
DELISTED
Target Global Acquisition I Corp. Class A Ordinary Share
TGAA
$9.17M 0.01%
925,763
+473,363
+105% +$4.69M
FCAX
921
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$9.17M 0.01%
931,320
+170,197
+22% +$1.68M
IGAC
922
DELISTED
IG Acquisition Corp. Class A Common Stock
IGAC
$9.17M 0.01%
926,668
+6,214
+0.7% +$61.5K
CLNE icon
923
Clean Energy Fuels
CLNE
$566M
$9.16M 0.01%
2,045,005
+463,513
+29% +$2.08M
APGB
924
DELISTED
Apollo Strategic Growth Capital II
APGB
$9.16M 0.01%
931,883
+75,000
+9% +$737K
GOGN
925
DELISTED
GoGreen Investments Corporation
GOGN
$9.16M 0.01%
913,818